194 related articles for article (PubMed ID: 29680768)
1. Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases.
Haque W; Verma V; Butler EB; Teh BS
Clin Genitourin Cancer; 2018 Aug; 16(4):e935-e943. PubMed ID: 29680768
[TBL] [Abstract][Full Text] [Related]
2. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.
Jiang W; Haque W; Verma V; Butler B; Teh BS
Acta Oncol; 2019 Apr; 58(4):491-498. PubMed ID: 30676131
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy: A Propensity Score Analysis and Predictors of Care for Patients With Brain Metastases From Breast Cancer.
Mainwaring W; Bowers J; Pham N; Pezzi T; Shukla M; Bonnen M; Ludwig M
Clin Breast Cancer; 2019 Apr; 19(2):e343-e351. PubMed ID: 30527350
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.
Bates JE; Youn P; Peterson CR; Usuki KY; Walter KA; Okunieff P; Milano MT
Am J Clin Oncol; 2017 Oct; 40(5):439-443. PubMed ID: 25730604
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors.
Ferrel EA; Roehrig AT; Kaya EA; Carlson JD; Ling BC; Wagner A; MacKay AR; Call JA; Demakas JJ; Lamoreaux WT; Fairbanks RK; Cooke BS; Peressini B; Lee CM
Int J Mol Sci; 2016 Mar; 17(3):400. PubMed ID: 26999120
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.
Wardak Z; Christie A; Bowman A; Stojadinovic S; Nedzi L; Barnett S; Patel T; Mickey B; Whitworth T; Hannan R; Brugarolas J; Timmerman R
Clin Genitourin Cancer; 2019 Apr; 17(2):e273-e280. PubMed ID: 30595522
[TBL] [Abstract][Full Text] [Related]
12. Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States.
Kann BH; Park HS; Johnson SB; Chiang VL; Yu JB
J Natl Compr Canc Netw; 2017 Dec; 15(12):1494-1502. PubMed ID: 29223987
[No Abstract] [Full Text] [Related]
13. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
14. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
15. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
16. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
17. Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma.
Barata PC; Mendiratta P; Kotecha R; Gopalakrishnan D; Juloori A; Chao ST; Koshkin V; Ornstein M; Gilligan TD; Wood LS; Rini BI; Angelov L; Garcia JA
Clin Genitourin Cancer; 2018 Oct; 16(5):413-419.e1. PubMed ID: 30172552
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
19. Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site.
Ostdiek-Wille GP; Amin S; Wang S; Zhang C; Lin C
PeerJ; 2023; 11():e15357. PubMed ID: 37223122
[TBL] [Abstract][Full Text] [Related]
20. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
